Study of Humoral and Cellular Immunogenicity of Split-vaccine to Swine-origin H1N1 Influenza.

Trial Profile

Study of Humoral and Cellular Immunogenicity of Split-vaccine to Swine-origin H1N1 Influenza.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Apr 2010 New trial record
    • 02 Apr 2010 Official title amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top